Fundraising Fox
Emergent Biosolutions
NYSE: EBSGaithersburg, US · Delaware corporation · 2 known investors
Find your way into Emergent Biosolutions
Sign up to see every warm intro you have to Emergent Biosolutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emergent Biosolutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic. It also provides in-house development and manufacturing support to biopharma innovators, governments, and non-governmental organizations.
Founders & leadership
RG
Robert G KramerRetiredRobert Kramer is president and CEO of Emergent BioSolutions, where he has held leadership positions for over two decades. The company develops and manufactures medical countermeasures for public health security and supplies biopharmaceutical manufacturing services.
KS
Katherine StreiExecutive
AR
Adam R HaveyExecutive Vice President & Chief Operating Officer2021–2023Adam R Havey served as Chief Operating Officer of Emergent BioSolutions from 2003 until late 2023, holding various leadership positions in manufacturing, operations, and biodefense. Prior to Emergent, he worked in product development at Eli Lilly and consulted for life sciences companies; he holds a bachelor's degree in chemical engineering from Michigan State University.
JC
Joseph C. PapaPresident, CEO and Director
ZH
Zsolt HarsanyiNamed on SEC filing
Board
GJ
George J. JoulwanBoard director
RB
Ronald B RichardBoard director
SB
Sue BaileyBoard director
LW
Louis W SullivanBoard director
KC
Kathryn C ZoonBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$47.9M disclosed across 1 round · 2018
▶$47.9MraisedOct 2018 · 8 investors · BiotechnologyRule 506(b)
▶$47.9MraisedOct 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George J. JoulwanDirector
- Robert G KramerExecutive Officer
- Ronald B RichardDirector
- Katherine StreiExecutive Officer
- Fuad El-HibriDirector, Executive Officer
- Adam R HaveyExecutive Officer
- Sue BaileyDirector
- Daniel J Abdun-NabiExecutive Officer, Director
- Louis W SullivanDirector
- Zsolt HarsanyiDirector
- Kathryn C ZoonDirector
- Jerome M HauerDirector
- Richard S. LindahlExecutive Officer
- Atul SaranExecutive Officer
- Offering amount
- $47.9M
- Amount sold
- $47.9M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
5 people who came through Emergent Biosolutions went on to found or lead other companies.
Laura SawardBioScience Division Executive Team and Vice President Research & DevelopmentFounded SynedgenJeremy GowlerVice President, Global Commercial - Vaccines Business UnitFounded OphirexZheng HuangHead of MSATFounded ArkJacqueline SheaVP Business Development, EuropeFounded Inovio PharmaceuticalsRay BarlowVP of Business DevelopmentFounded SynOx Therapeutics Ltd
Related companies · 2
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies working in the same space as Emergent Biosolutions.
Acquisitions · 1
Early investors' stakes continue via these dealsTrubion
Acquired by Emergent BioSolutions
Frequently asked questions
- What does Emergent Biosolutions do?
- Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic. It also provides in-house development and manufacturing support to biopharma innovators, governments, and non-governmental organizations.
- Who founded Emergent Biosolutions?
- Emergent Biosolutions was founded by Fuad El-Hibri.
- Who are Emergent Biosolutions's investors?
- Emergent Biosolutions's investors include Advent Life Sciences, OrbiMed.
- How much funding has Emergent Biosolutions raised?
- Emergent Biosolutions has disclosed $47.9M raised across 1 round.
- Where is Emergent Biosolutions headquartered?
- Emergent Biosolutions is headquartered in Gaithersburg, US.